Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.4 USD | -0.12% | +1.04% | +23.08% |
May. 15 | UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating | MT |
May. 09 | Crane NXT's Q1 Adjusted Earnings, Revenue Decline; 2024 Revenue Outlook Improved | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.08% | 8.31B | |
+10.46% | 15.38B | |
-22.86% | 11.64B | |
+3.14% | 7.17B | |
+48.05% | 2.16B | |
+17.91% | 1.78B | |
+16.99% | 982M | |
+20.15% | 930M | |
-6.63% | 649M | |
-20.92% | 404M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharma Gets Regulatory Nod to Amend Instructions for Lansoprazole for Injection